Pharma Capital

WideCells' Alan Greenberg on the 'extraordinary' opportunities for WideAcademy

WideCells Group PLC (LON:WDC) CEO Joao Andrade as well as Alan Greenberg,  Apple Inc’s (NASDAQ:AAPL) former head of education who's now tasked with heading up WideAcademy spoke to Proactive about their plans and strategy for the education and training division.

 

View full WDC profile

WideCells Group Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.